Comparative Effectiveness of Infliximab and Adalimumab for Crohn’s Disease

BACKGROUND & AIMS: Antibodies against tumor necrosis factor-α (anti-TNF) are widely used in the treatment of Crohn’s disease (CD). This study compared the effectiveness of infliximab and adalimumab, the two most commonly used anti-TNF medications for CD. METHODS: We conducted a retrospective coh...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Osterman, Mark T, Haynes, Kevin, Delzell, Elizabeth, Zhang, Jie, Bewtra, Meenakshi, Brensinger, Colleen, Chen, Lang, Xie, Fenlong, Curtis, Jeffrey R, Lewis, James D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3883891/
https://ncbi.nlm.nih.gov/pubmed/23811254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2013.06.010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi